Toll-like receptors and liver disease (Q38151944)

29 August 2017

title

Toll-like receptors and liver disease (English)

1 reference

29 August 2017

0 references

Vivek Kesar

1 reference

29 August 2017

Joseph A Odin

series ordinal

1 reference

29 August 2017

publication date

2 October 2013

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

184-196

1 reference

Toll-like receptors in the induction of the innate immune response

29 August 2017

cites work

1 reference

21 January 2018

TLRs and innate immunity

1 reference

Toll-like receptor signalling

21 January 2018

1 reference

The Structural Biology of Toll-like Receptors

21 January 2018

1 reference

Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection

21 January 2018

1 reference

Toll-like Receptor 4 and Hepatic Fibrogenesis

21 January 2018

1 reference

Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4.

21 January 2018

1 reference

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

Endogenous ligands of Toll-like receptors

21 January 2018

1 reference

Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells

21 January 2018

1 reference

Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling.

21 January 2018

1 reference

The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells

21 January 2018

1 reference

Toll-like receptors and their role in gastrointestinal disease.

21 January 2018

1 reference

Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors

21 January 2018

1 reference

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

21 January 2018

1 reference

Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling

21 January 2018

1 reference

SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling

21 January 2018

1 reference

Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88

21 January 2018

1 reference

Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1.

21 January 2018

1 reference

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.

21 January 2018

1 reference

A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells

21 January 2018

1 reference

The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon

21 January 2018

1 reference

IRAK-M is a negative regulator of Toll-like receptor signaling

21 January 2018

1 reference

TRAIL-R as a negative regulator of innate immune cell responses.

21 January 2018

1 reference

IL-10-inducible Bcl-3 negatively regulates LPS-induced TNF-alpha production in macrophages

21 January 2018

1 reference

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

21 January 2018

1 reference

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

21 January 2018

1 reference

Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide

21 January 2018

1 reference

Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages

21 January 2018

1 reference

Toll-like receptor signaling in the liver

21 January 2018

1 reference

Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation

21 January 2018

1 reference

Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge

21 January 2018

1 reference

Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells

21 January 2018

1 reference

Role of TLR9 in hepatic stellate cells and experimental liver fibrosis

21 January 2018

1 reference

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis

21 January 2018

1 reference

Lipopolysaccharide Activates Nuclear Factor-KappaB through Toll-Like Receptors and Related Molecules in Cultured Biliary Epithelial Cells

21 January 2018

1 reference

Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction

21 January 2018

1 reference

Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides.

21 January 2018

1 reference

Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver

21 January 2018

1 reference

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells

21 January 2018

1 reference

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production

21 January 2018

1 reference

Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists

21 January 2018

1 reference

B cell intrinsic TLR signals amplify but are not required for humoral immunity

21 January 2018

1 reference

Toll-like receptors and adaptor molecules in liver disease: update

21 January 2018

1 reference

Pattern recognition receptors: a contemporary view on liver diseases.

21 January 2018

1 reference

Toll-like receptors in acute liver injury and regeneration

21 January 2018

1 reference

Toll-like receptors in the pathogenesis of alcoholic liver disease.

21 January 2018

1 reference

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease

21 January 2018

1 reference

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice

21 January 2018

1 reference

Tlr2 is critical for diet-induced metabolic syndrome in a murine model.

21 January 2018

1 reference

Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

21 January 2018

1 reference

21 January 2018

Alcoholic liver disease

1 reference

Endotoxemia and gut barrier dysfunction in alcoholic liver disease

21 January 2018

1 reference

TLRs, Alcohol, HCV, and Tumorigenesis

21 January 2018

1 reference

Innate immunity in alcoholic liver disease

21 January 2018

1 reference

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

21 January 2018

1 reference

Reduced early alcohol-induced liver injury in CD14-deficient mice

21 January 2018

1 reference

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

21 January 2018

1 reference

Impaired antiviral response in human hepatoma cells.

21 January 2018

1 reference

TLRs antiviral effect on hepatitis B virus in HepG2 cells.

21 January 2018

1 reference

Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells

21 January 2018

1 reference

Toll-like receptor signaling inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines

21 January 2018

1 reference

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

Expression of Toll-like receptors in chronic hepatitis C virus infection

21 January 2018

1 reference

Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells

21 January 2018

1 reference

Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression

21 January 2018

1 reference

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

21 January 2018

1 reference

Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease

21 January 2018

1 reference

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection

21 January 2018

1 reference

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

21 January 2018

1 reference

A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection

21 January 2018

1 reference

Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection

21 January 2018

1 reference

Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis

21 January 2018

1 reference

Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

21 January 2018

1 reference

Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups

21 January 2018

1 reference

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis

21 January 2018

1 reference

Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis

21 January 2018

1 reference

Diagnosis and management of primary sclerosing cholangitis

21 January 2018

1 reference

High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6

21 January 2018

1 reference

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

21 January 2018

1 reference

Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling

21 January 2018

1 reference

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

Toll-like receptor signaling and liver fibrosis

21 January 2018

1 reference

Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses.

21 January 2018

1 reference

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

21 January 2018

1 reference

Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis

21 January 2018

1 reference

Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid

21 January 2018

1 reference

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis

21 January 2018

1 reference

Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog

21 January 2018

1 reference

Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4.

21 January 2018

1 reference

TLR4/MD-2 monoclonal antibody therapy affords protection in experimental models of septic shock

21 January 2018

1 reference

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.12315

1 reference

29 August 2017

1 reference